Ribociclib plus Endocrine Therapy in Early Breast Cancer
New England Journal of Medicine · 21.03.2024 · 390 (12) · 1080-1091
DOI: 10.1056/nejmoa2305488 ↗Kurz gefasst
Klinische Studie (Phase III) in der Zeitschrift New England Journal of Medicine, erschienen am 21.03.2024. Verfasst von Dennis Slamon und 30 weiteren Autor:innen. Beteiligte Einrichtung: From the David Geffen School of Medicine at the University of California, Los Angeles (D. Slamon, N.M.); Republican Clinical Oncology Dispensary, Ufa…. Hauptthemen laut MEDLINE: Antineoplastic Combined Chemotherapy Protocols, Breast Neoplasms, Letrozole, Aromatase Inhibitors. Die Arbeit wurde bisher 430-mal zitiert (Crossref) und nennt 31 Literaturangaben. Gefördert von: Novartis Pharmaceuticals Corporation.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- From the David Geffen School of Medicine at the University of California, Los Angeles (D. Slamon, N.M.); Republican Clinical Oncology Dispensary, Ufa (O.L.), and Moscow City Oncology Hospital No. 62, Moscow (D. Stroyako…
ORCID-Profile: Gabriel Hortobagyi
Förderung
- Novartis Pharmaceuticals Corporation
Zitieren
APA
Slamon, D., Lipatov, O., Nowecki, Z., McAndrew, N., Kukielka-Budny, B., Stroyakovskiy, D., Yardley, D. A., Huang, C. S., Fasching, P. A., Crown, J., Bardia, A., Chia, S., Im, S. A., Ruiz-Borrego, M., Loi, S., Xu, B., Hurvitz, S., Barrios, C., Untch, M., …, & Hortobagyi, G. (2024). Ribociclib plus Endocrine Therapy in Early Breast Cancer. New England Journal of Medicine, 390(12), 1080-1091. https://doi.org/10.1056/nejmoa2305488
Vancouver
Slamon D, Lipatov O, Nowecki Z, McAndrew N, Kukielka-Budny B, Stroyakovskiy D, et al. Ribociclib plus Endocrine Therapy in Early Breast Cancer. New England Journal of Medicine. 2024;390(12):1080-1091. doi:10.1056/nejmoa2305488
BibTeX
@article{Slamon2024,
author = {Slamon, Dennis and Lipatov, Oleg and Nowecki, Zbigniew and McAndrew, Nicholas and Kukielka-Budny, Bozena and Stroyakovskiy, Daniil and Yardley, Denise A and Huang, Chiun-Sheng and Fasching, Peter A and Crown, John and Bardia, Aditya and Chia, Stephen and Im, Seock-Ah and Ruiz-Borrego, Manuel and Loi, Sherene and Xu, Binghe and Hurvitz, Sara and Barrios, Carlos and Untch, Michael and Moroose, Rebecca and Visco, Frances and Afenjar, Karen and Fresco, Rodrigo and Severin, Irene and Ji, Yan and Ghaznawi, Farhat and Li, Zheng and Zarate, Juan P and Chakravartty, Arunava and Taran, Tetiana and Hortobagyi, Gabriel},
title = {Ribociclib plus Endocrine Therapy in Early Breast Cancer},
journal = {New England Journal of Medicine},
year = {2024},
volume = {390},
number = {12},
pages = {1080--1091},
doi = {10.1056/nejmoa2305488}
}
EUVIMED